Haplotype association between GABAA receptor γ2 subunit gene (GABRG2) and methamphetamine use disorder

Pharmacogenomics Journal

Volumn 5, Issue 2, 2005, Pages 89-95

  Nishiyama, T ^a,b   Ikeda, M ^a,c   Iwata, Nakao ^a,d   Suzuki, T ^a   Kitajima, T ^a   Yamanouchi, Y ^a   Sekine, Y ^d,e   Iyo, M ^d,f   Harano, M ^d,g   Komiyama, T ^d,h   Yamada, M ^d,h   Sora, I ^d,i   Ujike, H ^d,j   Inada, T ^c,d   Furukawa, T ^b   Ozaki, N ^c,d  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JGIDA ^*  (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

ⁱ TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j OKAYAMA UNIVERSITY   (Japan)

more..

Author keywords

GABAA 2 subunit gene; Haplotype; Methamphetamine; Polymorphism; Schizophrenia; Substance use disorder

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENINE; ASPARTIC ACID; CYTOSINE; DNA; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; SERINE; TYROSINE; 4 AMINOBUTYRIC ACID B RECEPTOR; CENTRAL STIMULANT AGENT; GABRR2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; DRUG DEPENDENCE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ALGORITHM; ALLELE; DRUG ABUSE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE;

ANIMALIA;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ALLELES; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METHAMPHETAMINE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA-B; SCHIZOPHRENIA;

EID: 20144389670     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500292     Document Type: Article

References (41)

1. Farrell M, Marsden J, Ali R, Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002; 97: 771-772.
2. UNDCP. United National International Drug Control Programme (UNDCP): World Drug Report. Oxford University Press: New York, 1997.
3. Sato M, Chen CC, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983; 18: 429-440.
4. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3372 twin pairs. Am J Med Genet 1996; 67: 473-477.
5. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55: 967-972.
6. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57: 261-269.
7. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999; 22: 521-527.
8. Gerasimov MR, Dewey SL. Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge. Eur J Pharmacol 1999; 380: 1-4.
9. Buck KJ, Finn DA. Genetic factors in addiction: QTL mapping and candidate gene studies implicate GABAergic genes in alcohol and barbiturate withdrawal in mice. Addiction 2001; 96: 139-149.
10. Lin SK, Chen CK, Ball D, Liu HC, Loh EW. Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder. Pharmacogenomics J 2003; 3: 349-355.
11. Loh EW, Higuchi S, Matsushita S, Murray R, Chen CK, Ball D. Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population. Mol Psychiatry 2000; 5: 301-307.
12. Agamma2 gene cluster and alcohol dependence in a Scottish population. Mol Psychiatry 2000; 5: 452.
13. Sander T, Ball D, Murray R, Patel J, Samochowiec J, Winterer G et al. Association analysis of sequence variants of GABA(A) alpha6, beta2, and gamma2 gene cluster and alcohol dependence. Alcohol Clin Exp Res 1999; 23: 427-431.
14. Simpson MD, Slater P, Deakin JF, Royston MC, Skan WJ. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 1989; 107: 211-215.
15. Reynolds GP, Czudek C, Andrews HB. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 1990; 27: 1038-1044.
16. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 1991; 121: 77-80.
17. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex 1995; 5: 550-560.
18. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000; 57: 237-245.
19. Gluck MR, Thomas RG, Davis KL, Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 2002; 159 1165-1173.
20. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061-1069.
21. Huntsman MM, Tran BV, Potkin SG, Bunney Jr WE, Jones EG. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-aminobutyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci USA 1998; 95: 15066-15071.
22. Kofuji P, Wang JB, Moss SJ, Huganir RL, Burt DR. Generation of two forms of the gamma-aminobutyric acidA receptor gamma 2-subunit in mice by alternative splicing. J Neurochem 1991; 56: 713-715.
23. Whiting P, McKernan RM, Iversen LL. Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site. Proc Natl Acad Sci USA 1990; 87: 9966-9970.
24. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997; 2: 148-155.
25. Kendler KS, Myers JM, O'Neill FA, Martin R, Murphy B, MacLean CJ et al. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 2000; 157: 402-408.
26. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001; 68: 661-673.
27. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
28. Zhang L, Ashiya M, Sherman TG, Grabowski PJ. Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA. RNA 1996; 2: 682-698.
29. Zhang L, Liu W, Grabowski PJ. Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA 1999; 5: 117-130.
30. Ashiya M, Grabowski PJ. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 1997; 3: 996-1015.
31. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ et al. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 2000; 25: 359-371.
32. Dredge BK, Darnell RB. Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol 2003; 23: 4687-4700.
33. Collins JS, Schwartz CE. Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet 2002; 71: 1251-1252.
34. Smoller JW, Lunetta KL, Robins J. Implications of comorbidity and ascertainment bias for identifying disease genes. Am J Med Genet 2000; 96: 817-822.
35. Substance Abuse Department, W.H.O.. Amphetamine-Type Stimulants: A Report from the WHO Meeting on Amphetamine, MDMA and Other Psychostimulants, Geneva, 12-15 November 1996.
36. Karler R, Calder LD, Thai DK, Bedingfield JB. The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine. Pharmacol Biochem Behav 1998; 60: 237-244.
37. Abeta2 and gamma2 gene polymorphisms with event-related prefrontal activity in man. Hum Genet 2000; 107: 513-518.
38. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y et al. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 2003; 3: 242-247.
39. Suzuki T, Iwata N, Kitamura Y, Kitajima T, Yamanouchi Y, Ikeda M et al. Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia. Am J Med Genet 2003; 121B: 7-13.
40. Hoogendoorn B, Owen MJ, Oefner PJ, Williams N, Austin J, O'Donovan MC. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum Genet 1999; 104: 89-93.
41. Schneider S, Roessli D, Excoffier L. Arlequin: A software for population genetics data analysis. Ver. 2.000. 2000.